SPP Abstract Submission - Banff, Alberta

Submission Deadline is Friday, June 4, 2010 (11:59 PM PST; GMT -08:00)
Steps to submit an abstract to the SPP-PPS Meeting:

Must Read: There is only one box for the abstract body. Text within the abstract body that is regarded as "identifying the source" is to be marked by the author(s) by enclosing it with triple parentheses. Example: A series of 100 cases from the files of ((( The Antarctic School of Medicine))) was studied. The copy sent to the reviewers will be edited to: A review of the files of the _____ School of Medicine was done.

The online submission will give you instant feedback that your abstract has been received. If you do not receive email confirmation within 48 hours you must contact Carolyn Lane at USCAP immediately (email: carolyn@uscap.org or call 706-733-7550, USA). Paper and email submissions will not be accepted. Start the process by downloading the general instructions. The sample canvas and offline character checker are optional tools (see instructions). To download in Windows, right click the links below and select "save target as". Alternatively,click the links, and when the page opens, click the file tab and "save as". Downloading methods differ in different operating systems and internet browsers.

Contact Carolyn Lane (USCAP) if you need assistance(email: carolyn@uscap.org or call 706-733-7550, USA)

General Instructions: Word RTF file    PDF file

Sample Canvas:  Word RTF file

Offline Character Checker:  html  (opens in web browser)

Submission Process
1. Read the instructions and prepare the abstract offline:
  (remember to mark identifiers in the abstract body with triple parentheses; this marking method is not used in the author-institution fields)
2. Return to this online site:
  - Fill in the required fields in the form below.
  - Copy and paste your Title into the appropriate box below.
  - Copy and paste your Authors into the appropriate box below.
  - Copy and paste your Institutions into the appropriate box below.
  - Copy and paste your Abstract Body into the appropriate box below.
  - Click "Submit My Abstract"

Important Notes:
1. Most fields below are required. Optional fields are italicized
2. You will not be allowed to submit the abstract until required fields are filled.
3. The primary contact is the only person that will receive communication regarding this abstract. If you are a resident or fellow, you may list yourself as the primary contact, but remember to then fill in the box designating the senior author and/or sponsoring member. If your attending physician is listed as the primary contact, you must rely on them to forward communication about acceptance and presentation type to you. Status of the abstract review process is also posted on the web site to include target dates when they are known.
Primary Contact
Name:      
Address:  
Address:  
Address:  
Address:  
Email:      
Phone:     
Fax:         
Name of presenter if not first author:


Name of senior author (if different):


Name of SPP-PPS sponsoring member (if indicated):


Presentation Type Preferred:    Platform or Poster  Poster Only

Eligible for Vawter Award:        Yes  No   (Enter yes if you are in training and want to be considered. Applicants include medical students, residents, fellows, or equivalent status in pathology or pediatric pathology. Details in the instructions and on the SPP website www.spponline.org)

SOCIETY FOR PEDIATRIC PATHOLOGY
Faculty Disclosure Declaration  (must be completed):

As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Society for Pediatric Pathology must ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly sponsored educational activities. All faculty participating in a sponsored activity are expected to disclose if they or their spouse/partner have any significant financial interest or other relationship (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. (A "significant financial interest or other relationship" can include such things as grants or research support, status as an employee, consultant, major stock holder, member of speakers bureau, etc.) The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide listeners with information on which they can base their own judgments as to whether the speaker's interests or relationships influenced the presentation with regard to exposition or conclusion.

 I.   Yes    No   Will your presentation include discussion of any commercial products or services?
 Yes    No   Do you or your spouse/partner have a significant financial interest or other relationship with
                             a product manufacturer(s) or provider(s) of services you intend to discuss?
  If yes, please disclose (below) the identity of the manufacturer(s) or provider(s) and
  describe the nature of the relationship(s).
 II.   Yes    No   Is the work you are presenting financially supported by a corporation?
 Yes    No   Do you or your spouse/partner have a significant relationship(s) with a commercial supporter(s)
                             funding the work you are presenting?
  If yes, please disclose (below) the identity of the relevant commercial supporter(s) and describe
  the nature of the relationship(s).
 III.   Yes    No   Will you be discussing any unlabeled or investigational uses of products?
  If yes, be ACCME guidelines require that you disclose the off-label use(s) in your presentation.
 IV.    I have followed all appropriate governmental regulations and have obtained institutional approval where necessary
  (for USA - compliance with HIPPA and IRB). I realize that failure to do so does not transfer liability to
  the Society of Pediatric Pathology or the Paediatric Pathology Society for inappropriate conduct on my part.
  “Signature” (required) – Entrance of my name into the field below indicates that I agree to abide by this disclosure.   


IMPORTANT: After pasting into each field below, you must click into the field and hit the up arrow or another key in order to update the character checker. If you re-populate a field higher in the form, you must re-click into lower fields and repeat the maneuver as the checker adds the characters from the top box (Abstract Title:) to the lower one (Abstract Body).

2764 characters allowed :  Characters remaining  

Abstract Title:


Authors:


Institutions:


Abstract Body:
Remember:
1. Check that the end of the abstract has not been chopped off if you have "0" characters remaining.
2. Abstract appearance in this box may be distorted compared with the appearance in the word processor - do not try to fix this, it is expected.
    Your published appearance will match that seen in the word processor.
3. You must use the exact headers: Background:, Design:, Results:, Conclusion:.
    Please remember to put the colon and one space after the header (not optional)
4. Mark identifiers in the abstract body with triple parentheses



    

{back to home page}